About FDA
Percent of Office of Surveillance and Biometrics (OSB) intra- and inter-Office eConsults completed on time during the month
Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.
Data is current as of December 31, 2012
Fiscal Year - 2013
| Time | Target | Percent |
|---|---|---|
| Oct 2012 | 85 | 93 |
| Nov 2012 | 85 | 91 |
| Dec 2012 | 85 | 92 |
| Jan 2013 | 85 | TBD |
| Feb 2013 | 85 | TBD |
| Mar 2013 | 85 | TBD |
| Apr 2013 | 85 | TBD |
| May 2013 | 85 | TBD |
| Jun 2013 | 85 | TBD |
| Jul 2013 | 85 | TBD |
| Aug 2013 | 85 | TBD |
| Sep 2013 | 85 | TBD |
FY 2013 YTD: 92%
Number of OSB intra- and inter-Office eConsults completed on time during the month
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 264 |
| Nov 2012 | N/A | 230 |
| Dec 2012 | N/A | 258 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 752
Total number of OSB intra- and inter-Office eConsults completed during the month
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 285 |
| Nov 2012 | N/A | 254 |
| Dec 2012 | N/A | 280 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 819
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
